Skip to main navigation Skip to search Skip to main content

Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

Peripheral artery disease (PAD) is a major health problem with increased cardiovascular mortality, morbidity and disabling critical limb threatening ischemia (CLTI) and amputation. Diabetes mellitus (DM) and cigarette smoke are the main risk factors for the development of PAD. Although diabetes related PAD shows an accelerated course with worse outcome regarding complications, mortality and amputations compared with non-diabetic patients, current medical treatment does not make this distinction and includes standard antiplatelet and lipid lowering drugs for all patients with PAD. In this review we discuss the pathophysiologic mechanisms of PAD, with focus on differences in thrombo-inflammatory processes between diabetes-related and smoking-related PAD, and hypothesize on possible mechanisms for the progressive course of PAD in DM. Furthermore, we comment on current medical treatment and speculate on alternative medical drug options for patients with PAD and DM.
Original languageEnglish
Article number257
Number of pages13
JournalCardiovascular Diabetology
Volume22
Issue number1
DOIs
Publication statusPublished - 21 Sept 2023

Keywords

  • Diabetes mellitus
  • Inflammation
  • Peripheral artery disease
  • Smoking
  • Thrombosis

Fingerprint

Dive into the research topics of 'Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease'. Together they form a unique fingerprint.

Cite this